Detalhe da pesquisa
1.
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Nature
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588696
2.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
3.
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
Diabetologia
; 64(2): 288-303, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164108
4.
Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy.
Curr Cardiol Rep
; 23(3): 16, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501515
5.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Lancet Oncol
; 21(10): 1296-1308, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919527
6.
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Breast Cancer Res
; 21(1): 58, 2019 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060593
7.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Breast Cancer Res Treat
; 174(3): 731-740, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656459
8.
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Breast Cancer Res
; 19(1): 7, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095868
9.
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
PLoS Genet
; 10(4): e1004285, 2014 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24743323
10.
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer.
Breast Cancer Res Treat
; 148(1): 221-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25288231
11.
Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.
Trials
; 25(1): 228, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566197
12.
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction.
J Pathol
; 226(3): 482-94, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953249
13.
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Nat Genet
; 30(4): 406-10, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11865300
14.
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
Cancers (Basel)
; 15(17)2023 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686673
15.
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function.
Cancer Med
; 12(17): 17856-17865, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610318
16.
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).
Clin Cancer Res
; 29(23): 4751-4759, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773077
17.
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
JAMA Oncol
; 9(2): 188-196, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547970
18.
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Sci Rep
; 13(1): 11327, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491478
19.
Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer.
JCO Precis Oncol
; 6: e2100002, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005994
20.
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728876